Role of Karveeradi Tail in the management of Pama.

Study on the efficacy of Karveeradi Tail in the management of Pama with special reference to Scabies.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030705

Enrollment

Registered

2021-01-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B998- Other infectious disease

Interventions

Intervention1: karveeradi tail: karveeradi tail will be locally applied to 20 participants over the affected area in qunatity sufficient ammount twice a day for seven days in the case of pama(scabies)

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of Pamakustha/Scabies with the symptoms Kandu, Toda, Daha, Pidika, Strav

Exclusion criteria

Exclusion criteria: 1. Patient suffering from any other systemic disorder such as skin tuberculosis, leprosy etc. 2. Scabies with complication crust or hyperkeratosis and secondary infections. 3. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Efficacy of Karveeradi Tail in PamaTimepoint: Efficacy of Karveeradi Tail in Pama in 21 days	—

Secondary

Measure	Time frame
1. To study physio-chemical parameters of karveeraditail. 2. To study the efficacy of karveeradi tail in the management of Kandu, Toda ,Daha, Pidika and Strav. 3. To compare the efficacy of karveeraditail with standard drug(Permethrin).Timepoint: Follow up will be on zero, 3rd, 7th, 14th, 21th	—

Countries

India

Contacts

Public ContactKanchan Gaidhani

Mahatma Gandhi Ayurved College Hospital and Research Centre

spchalakh@gmail.com9850366073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026